Apollo Endosurgery, Inc.

APEN · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$39,839-$24,682-$22,611-$27,432
Dep. & Amort.$2,966$3,232$3,730$4,060
Deferred Tax$0-$3,094$1,310$160
Stock-Based Comp.$6,783$6,386$2,114$1,487
Change in WC-$6,938$710-$7,512$552
Other Non-Cash$5,766$2,994$2,157-$4,449
Operating Cash Flow-$31,262-$14,454-$20,812-$25,622
Investing Activities
PP&E Inv.-$2,745-$1,456-$630-$980
Net Acquisitions$0$3,000$2,000$2,000
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$17$0$18
Investing Cash Flow-$2,745$1,561$1,370$1,038
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$1,226$69,782$23,262$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$349$67,582$25,613$30,506
Financing Cash Flow$349$67,582$25,613$30,506
Forex Effect-$142-$77$108-$8
Net Chg. in Cash-$33,800$54,612$6,279$5,914
Supplemental Information
Beg. Cash$91,812$37,200$30,921$25,007
End Cash$58,012$91,812$37,200$30,921
Free Cash Flow-$34,007-$15,910-$21,442-$26,602
Apollo Endosurgery, Inc. (APEN) Financial Statements & Key Stats | AlphaPilot